Recombinant human erythropoietin therapy and autonomic nervous system.
Suwata
J
J
Maeda
H
H
Ohmori
N
N
Ohwa
M
M
Ohtsuka
H
H
Shimoyama
H
H
D000328:Adult; D000740:Anemia / Q000209:etiology / Q000628:therapy*; D001341:Autonomic Nervous System / Q000187:drug effects / Q000503:physiopathology*; D001794:Blood Pressure / Q000187:drug effects; D004299:Dopamine beta-Hydroxylase / Q000097:blood; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D005921:Glomerulonephritis / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009393:Nephritis / Q000209:etiology / Q000628:therapy*; D009638:Norepinephrine / Q000378:metabolism*; D011225:Pre-Eclampsia / Q000503:physiopathology*; D011247:Pregnancy; D011994:Recombinant Proteins / Q000627:therapeutic use; D006435:Renal Dialysis / Q000009:adverse effects*
D011994:Recombinant Proteins; D004921:Erythropoietin; D004299:Dopamine beta-Hydroxylase; D009638:Norepinephrine